JPRN-UMIN000004550已完成3 期
RANDOMIZED PHASE III CLINICAL TRIAL OF ADJUVANT RADIATION VERSUS CHEMORADIATION IN INTERMEDIATE RISK, STAGE I/IIA CERVICAL CANCER TREATED WITH INITIAL RADICAL HYSTERECTOMY AND PELVIC LYMPHADENECTOMY - GOG-0263
RG Oncology0 个研究点目标入组 360 人开始时间: 2010年11月12日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 360
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1) Patients with tumor in the parametria, pelvic lymph nodes or any other extra uterine site or with positive surgical margins. 2) Patients with septicemia or severe infection. 3) Patients with intestinal obstruction or gastrointestinal bleeding. 4) Patients with postoperative fistula. 5) Patients with cervix cancer who have received any previous radiation or chemotherapy. 6) Patients whose circumstances do not permit completion of the study or the required follow-up. 7) Patients with renal abnormalities requiring modification of radiation field (pelvic kidney, renal transplant, etc). 8) Patients with GOG Performance Status of 3 or 4. 9) Patients with a history of other invasive malignancies, with the exception of non-melanoma skin cancer, are excluded if there is any evidence of other malignancy being present within the last five years. Patients are also excluded if their previous cancer treatment contraindicates this protocol therapy.
研究者
相似试验
招募中
不适用
Randomized phase III clinical trial of adjuvant radiation versus chemo-radiation in intermediate risk, stage I/IIa cervical cancer treated with initial radical hysterectomy and pelvic lymphadenectomyNeoplasmsKCT0003504Asan Medical Center360
招募中
不适用
Randomized Phase III Trial of the need for adjuvant chemotherapy in stage I epithelial ovarian cancer after comprehensive staging surgeryKCT0005869The Catholic University of Korea, Seoul St. Mary's Hospital360
招募中
3 期
Randomized Phase III Trial of the need for adjuvant chemotherapy in stage I epithelial ovarian cancer after comprehensive staging surgeryStage I epithelial ovarian cancer after comprehensive staging surgeryJPRN-UMIN000008481Japanese Gynecologic Oncology Group360
招募中
3 期
Japanese Gynecologic Oncology Group 3020 (ECO trial)Early OvarianCancerD000077216Epithelial ovarian cancerJPRN-jRCTs031180423TANABE HIROSHI300
已完成
不适用
Randomised phase III clinical trial in patients radically operated for stage III melanoma (American Joint Committee on Cancer [AJCC]): comparison between Interferon (IFN) alpha-2b (sec Eastern Cooperative Oncology Group [ECOG] 1684) versus intensified Interferon alpha-2bCancerISRCTN75125874Italian Melanoma Intergroup - IMI (Italy)328